Pre-Clinical SARMs: Targeting Androgen Receptors with Precision
Pre-Clinical SARMs, or Selective Androgen Receptor Modulators, are investigational compounds designed to stimulate androgen receptors in muscles and bones, aiming to enhance growth and strength while reducing side effects typical of steroids. These compounds are rigorously tested in labs and on animals to assess their efficacy, safety, and potential in treating conditions like muscle wasting and osteoporosis. While promising, they’re not yet approved for human use, highlighting the need for further research to ensure their safety and effectiveness.
